CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

DIVI'S LABORATORIES LTD.

NSE : DIVISLABBSE : 532488ISIN CODE : INE361B01024Industry : Pharmaceuticals & DrugsHouse : Divis Labs
BSE5782.6025.1 (+0.44 %)
PREV CLOSE () 5757.50
OPEN PRICE () 5757.45
BID PRICE (QTY) 5761.55 (8)
OFFER PRICE (QTY) 5776.75 (15)
VOLUME 113
TODAY'S LOW / HIGH ()5755.00 5795.75
52 WK LOW / HIGH ()3640.1 6448.75
NSE5750.00-4 (-0.07 %)
PREV CLOSE() 5754.00
OPEN PRICE () 5750.00
BID PRICE (QTY) 5745.00 (1)
OFFER PRICE (QTY) 5746.00 (32)
VOLUME 194
TODAY'S LOW / HIGH() 5750.00 5750.00
52 WK LOW / HIGH ()3641 6285.45
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1990

Management Info :

Ramesh BV Nimmagadda - Chairman Murali K Divi - Managing Director

Registered Office :

Address : 1-72/23( P)/ Divis/303,Divi Towers, Cyber Hills,Gachibowli,
Hyderabad,
Telangana-500032

Phone : 040 66966300 / 400

Website : www.divislabs.com

Registrar's Details : K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE
NEWS
31Mar Divi's Laboratories informs about cess
Divi's Laboratories has informed that G. Bala Kishore, serving as Genera..
31Mar Divis Laboratories informs about tradi
Divis Laboratories has informed that the Trading Window for dealing in s..
21Feb Divi's Laboratories informs about disc
Divi's Laboratories has informed that the exchange has received the disc..
03Feb Divi's Laboratories informs about inte
Pursuant to SEBI Circular No. SEBI/HO/CFD/CFD-PoD-2/CIR/P/2024/185 dated..
02Jan Divi's Laboratories starts commercial
Divi's Laboratories has commenced commercial operations from a part of t..
Financials
in Millions
QTR Dec 24 ANNUAL 24
Net Profit594015760
Gross Profit 7300 21320
Operating Profit 829025110
Net Sales 2297076650
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 30909.95 (0.63%)
M.Cap ( in Cr)
65268.93
Neuland Laboratories (BSE)
 12911.90 (1.33%)
M.Cap ( in Cr)
16347.97
TTK Healthcare (BSE)
 1325.00 (7.57%)
M.Cap ( in Cr)
1751.17
Astrazeneca Pharma I (BSE)
 8595.00 (0.99%)
M.Cap ( in Cr)
21277.50
Alkem Laboratories (BSE)
 4987.35 (0.62%)
M.Cap ( in Cr)
59262.39
Shareholding Pattern
PROMOTERS 51.89%
MUTUAL FUNDS/UTI 11.89%
NON-INSTITUTION 9.59%
FI/BANKS/INSURANCE 7.73%
GOVERNMENT 0%
FII 0%

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by  Accord Fintech Pvt. Ltd.
SENSEX76968.02-76.27 (-0.10%)
NIFTY23405.10-32.10 (-0.14%)
Dow Jones 39669.39-699.57 (-1.73%)
Nasdaq 16307.16-516.01 (-3.07%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI